MAIA Biotechnology, Inc. Increase (Decrease) in Accrued Liabilities
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2026-08-10
- MAIA Biotechnology, Inc. increase (decrease) in accrued liabilities for the quarter ending 2026-06-30 was $80.75K, a 40.08% decline year-over-year.
- MAIA Biotechnology, Inc. increase (decrease) in accrued liabilities for the quarter ending 2026-03-31 was -$458.39K, a 152.86% decline year-over-year.
- MAIA Biotechnology, Inc. increase (decrease) in accrued liabilities for the quarter ending 2025-12-31 was -$3.02M.
- MAIA Biotechnology, Inc. increase (decrease) in accrued liabilities for the quarter ending 2025-09-30 was $3.50M, a 1574.67% increase year-over-year.
- MAIA Biotechnology, Inc. increase (decrease) in accrued liabilities for fiscal 2025 was $1.48M.
- MAIA Biotechnology, Inc. increase (decrease) in accrued liabilities for fiscal 2024 was -$979.79K, a 145.15% decline from fiscal 2023.
- MAIA Biotechnology, Inc. increase (decrease) in accrued liabilities for fiscal 2023 was $2.17M, a 136.96% increase from fiscal 2022.
- MAIA Biotechnology, Inc. increase (decrease) in accrued liabilities for fiscal 2022 was $915.74K, a 8.16% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 3 month as first filed | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $80.75K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$377.64K 10-Q · filed 2026-08-10 | -$3.40M derived: sum of 3 quarters · filed 2026-08-10 | $99.37K derived: sum of 4 quarters · filed 2026-08-10 | |
| 2026-03-31 | -$458.39K 10-Q · filed 2026-05-11 | -$3.48M derived: sum of 2 quarters · filed 2026-05-11 | $18.62K derived: sum of 3 quarters · filed 2026-05-11 | $153.38K derived: sum of 4 quarters · filed 2026-08-10 | |
| 2025-12-31 | -$3.02M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | $477.01K derived: sum of 2 quarters · filed 2026-03-23 | $611.77K derived: sum of 3 quarters · filed 2026-08-10 | $1.48M 10-K · filed 2026-03-23 | |
| 2025-09-30 | $3.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $3.63M derived: sum of 2 quarters · filed 2026-08-10 | $4.50M 10-Q · filed 2025-11-07 | $4.36M derived: sum of 4 quarters · filed 2026-08-10 | |
| 2025-06-30 | $134.76K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $1.00M 10-Q · filed 2026-08-10 | $864.03K derived: sum of 3 quarters · filed 2026-08-10 | $1.07M derived: sum of 4 quarters · filed 2026-08-10 | |
| 2025-03-31 | $867.18K 10-Q · filed 2026-05-11 | $729.27K derived: sum of 2 quarters · filed 2026-05-11 | $938.15K derived: sum of 3 quarters · filed 2026-05-11 | $163.15K derived: sum of 4 quarters · filed 2026-05-11 | |
| 2024-12-31 | -$137.92K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | $70.97K derived: sum of 2 quarters · filed 2026-03-23 | -$704.03K derived: sum of 3 quarters · filed 2026-03-23 | -$979.79K 10-K · filed 2026-03-23 | |
| 2024-09-30 | $208.88K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$566.12K derived: sum of 2 quarters · filed 2025-11-07 | -$841.87K 10-Q · filed 2025-11-07 | -$468.45K derived: sum of 4 quarters · filed 2025-11-07 | |
| 2024-06-30 | -$775.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | -$1.05M 10-Q · filed 2025-08-11 | -$677.34K derived: sum of 3 quarters · filed 2025-08-11 | $523.73K derived: sum of 4 quarters · filed 2025-08-11 | |
| 2024-03-31 | -$275.76K 10-Q · filed 2025-05-09 | $97.66K derived: sum of 2 quarters · filed 2025-05-09 | $1.30M derived: sum of 3 quarters · filed 2025-05-09 | $1.89M derived: sum of 4 quarters · filed 2025-05-09 | |
| 2023-12-31 | $373.42K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-21 | $1.57M derived: sum of 2 quarters · filed 2025-03-21 | $2.16M derived: sum of 3 quarters · filed 2025-03-21 | $2.17M 10-K · filed 2025-03-21 | |
| 2023-09-30 | $1.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $1.79M derived: sum of 2 quarters · filed 2024-11-12 | $1.80M 10-Q · filed 2024-11-12 | $2.46M derived: sum of 4 quarters · filed 2024-11-12 | |
| 2023-06-30 | $587.22K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $595.43K 10-Q · filed 2024-08-09 | $1.26M derived: sum of 3 quarters · filed 2024-08-09 | $640.12K derived: sum of 4 quarters · filed 2024-08-09 | |
| 2023-03-31 | $8.21K 10-Q · filed 2024-05-14 | $534.69K 10-Q · filed 2023-05-08 | $671.46K derived: sum of 2 quarters · filed 2024-05-14 | $52.90K derived: sum of 3 quarters · filed 2024-05-14 | $571.08K derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $663.25K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | $44.69K derived: sum of 2 quarters · filed 2024-03-21 | $562.87K derived: sum of 3 quarters · filed 2024-03-21 | $915.74K 10-K · filed 2024-03-21 | |
| 2022-09-30 | -$618.56K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | -$100.39K derived: sum of 2 quarters · filed 2023-11-07 | $252.49K 10-Q · filed 2023-11-07 | $904.67K derived: sum of 4 quarters · filed 2023-11-07 | |
| 2022-06-30 | $518.17K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $871.05K 10-Q · filed 2023-08-08 | $1.52M derived: sum of 3 quarters · filed 2023-08-08 | $1.77M derived: sum of 4 quarters · filed 2023-08-08 | |
| 2022-03-31 | $352.87K 10-Q · filed 2023-05-08 | $1.01M derived: sum of 2 quarters · filed 2023-05-08 | $1.25M derived: sum of 3 quarters · filed 2023-05-08 | ||
| 2021-12-31 | $652.19K derived: 10-K 12 month − 10-Q/A 9 month · filed 2023-03-24 | $900.20K derived: sum of 2 quarters · filed 2023-03-24 | $997.13K 10-K · filed 2023-03-24 | ||
| 2021-09-30 | $248.02K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2023-02-06 | $344.94K 10-Q/A · filed 2023-02-06 | |||
| 2021-06-30 | $96.92K 10-Q · filed 2022-08-22 |